Assistant Professor, Internal Medicine, University of Utah School of Medicine
Cardiology
Dr. Stavros G. Drakos, MD
|
|
Give Review
Dr. Stavros G. Drakos practices Cardiology. Stavros Drakos is a published doctor and has 46 publications published. The lastest was: 'ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.' He accepts Medicare.
Publications
- Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed Hearts.
- Mixed cellular and antibody-mediated rejection in Heart transplantation: In-depth pathologic and clinical observations.
- Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility.
- Bridge to Removal: A Paradigm Shift for Left Ventricular Assist Device Therapy.
- Myocardial atrophy and Chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.
- Characterization of diffuse fibrosis in the failing human Heart via diffusion tensor imaging and quantitative histological validation.
- Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis.
- Cardiac, Skeletal, and smooth muscle mitochondrial respiration: Are all mitochondria created equal?
- Spotlight on cardiogenic shock therapies in the era of mechanical circulatory support.
- Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials.
- The Odyssey of Chronic Cardiac Mechanical Support.
- Ventricular Assist Devices or Inotropic Agents in Status 1A Patients? Survival Analysis of the United Network of Organ Sharing Database.
- Reply to Letter to the Editor: Left ventricular assist devices in Chronic heart failure: more questions than answers?
- Autophagy is a key feature in the pathogenesis of systemic sclerosis.
- Magnitude and Time Course of Changes Induced by Continuous-Flow Left Ventricular Assist Device Unloading in Chronic Heart Failure: Insights into Cardiac Recovery.
- Pulsatility and the Risk of Non-Surgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II.
- Morbidity and mortality in Heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing th...
- Impact of Ventricular Assist Device Complications on Posttransplant Survival: An Analysis of the United Network of Organ Sharing Database.
- Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.
- Bridge to recovery: understanding the disconnect between clinical and biological outcomes.
- Vascular Leak Is a Central Feature in the Pathogenesis of Systemic Sclerosis.
- Ventricular assist devices: Pharmacological aspects of a mechanical therapy.
- Improved survival in Heart transplant patients living at high altitude.
- A longitudinal study of the course of asymptomatic antibody-mediated rejection in Heart transplantation.
- Impact of donor left ventricular hypertrophy on survival after Heart transplant.
- Allograft rejection in patients supported with continuous-flow left ventricular assist devices.
- Changing outcomes in patients bridged to Heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the In...
- Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice.
- Left ventricular assist device unloading effects on Myocardial structure and function: current status of the field and call for action.
- End-of-life decision making and implementation in recipients of a destination left ventricular assist device.
- Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection.
- Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human Heart.
- The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
- Risk factors predictive of right ventricular Failure after left ventricular assist device implantation.
- Impact of donor cause of death on transplant outcomes: UNOS registry analysis.
- Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.
- The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.
- Similar transplantation outcomes in patients bridged with cardiac assist devices for Acute cardiogenic shock versus chronic heart failure.
- Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.
- Ventricular-assist devices for the treatment of Chronic heart failure.
- Effect of reversible Pulmonary hypertension on outcomes after heart transplantation.
- Multivariate predictors of heart transplantation outcomes in the era of Chronic mechanical circulatory support.
- Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
- Effect of mechanical circulatory support on outcomes after Heart transplantation.
- ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Education
-
University of Athens
Hospital
-
University of Utah Health Care - Hospital and Clinics
Drug Facts
| NPI NUMBER | 1457627192 | |
| NPPES Provider LastName | DRAKOS | |
| NPPES Provider FirstName | STAVROS | |
| NPPES Provider ZIPCode | 841320001 | |
| NPPES Provider State | UT | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 226.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457627192 |
| Last Name Of The Provider | DRAKOS |
| First Name Of The Provider | STAVROS |
| View All |
Similar Doctors
|
|
Dr. Edward G. Jenkins, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald L. Lappe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin J. Walsh, MD |
|
Dr. Charles W. Tate, MD |
|
Dr. Ronald E. Brown, MD
This Doctor is OpenDoctor Recommended.
|